U.S. Seeks to Pause J&J Covid-19 Vaccine Use Amid Clotting Reports

  • 📰 WSJ
  • ⏱ Reading Time:
  • 11 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 8%
  • Publisher: 63%

United States Headlines News

United States Latest News,United States Headlines

The U.S. recommended pausing use of Johnson & Johnson's Covid-19 vaccine as the FDA reviews rare blood-clotting cases

U.S. health authorities recommended a pause in the use of Johnson & Johnson ’s Covid-19 vaccine after reports of rare blood clotting in recipients of the shot based in the U.S.

The Food and Drug Administration said in a tweet Tuesday that it and the Centers for Disease Control and Prevention were reviewing data involving six reported cases of clotting.To Read the Full Story

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.

If you randomly pick 6 million people, how many would have blood clots?

Weird, a drug that didn’t go through a proper release cycle potentially has issues that could’ve been easily observed in a full clinical trial process...

The world is treating me bad... Misery

Keep drinking that kool-aid America

If I remember correctly, that's what pritzker had. Bummer.

This is that part of I Am Legend when things start going to shit

All about the money and the political clout of Pfizer and Moderna.

Article states that there were 6 cases. Are these 6 cases out of all who have been vaccinated? Or what is the sample size?

Pfizer just called, we still have a vaccine.

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 98. in US

United States Latest News, United States Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

U.S. urges pause in use of Johnson & Johnson COVID-19 vaccine over blood clot concernsFederal health officials said Tuesday that they were urging a pause in the use of Johnson & Johnson’s COVID-19 vaccine after reports of six serious blood clots. The announcement is a severe blow to the U.S. vaccination campaign, which has counted on public faith in the rapidly developed inoculations and growing supplies in order to protect Americans from the coronavirus and bring an end to the pandemic.
Source: latimes - 🏆 11. / 82 Read more »

No Need for Panic Over J&J Covid-19 Vaccine PauseThe Johnson & Johnson shot rollout pause after blood-clot cases should boost confidence in Covid-19 vaccine safety, not erode it. wsjheard explains. WSJWhatsNow heard heard Women that have not enter in their Menopause cycle should take into consideration the J&J or Astrazeneca vacine. Why you may ask, that´s CDC job to find out, but it has something to do with hormones. But for Men, If you want to continued, go ahead. Tell J&J, CDC,FDA they own me!
Source: WSJ - 🏆 98. / 63 Read more »

J&J Covid-19 Vaccine Pause Spotlights Science of Rare Clotting DisorderScientists are racing to understand a rare blood clotting disorder that affected six recipients of Johnson & Johnson’s Covid-19 vaccine and led U.S. health authorities to recommend a pause in its use oh please...come on..who would believe that just after 6 cases this govermnent would shot down the vaccination...more like 600? or 6000?... Is there a correlation with taking pills? Brain Thrombosis is a very rare disease. Check AstraZeneca and JohnsonandJohnson Jabs for common ingredient COVID19 vaccine
Source: WSJ - 🏆 98. / 63 Read more »

The Reasons Behind The FDA, CDC Pause On Johnson & Johnson Covid-19 VaccinesSome such as Nate Silver, the founder and editor in chief of FiveThirtyEight, have criticized the pause. But how strong are Silver's arguments?
Source: Forbes - 🏆 394. / 53 Read more »

WSJ News Exclusive | J&J Covid-19 Vaccine Pause Driven by Risk of Mistreating Blood ClotsHealth authorities came close to simply warning about a blood-clotting risk from Johnson & Johnson’s Covid-19 vaccine, but decided to recommend pausing use out of concern doctors would improperly treat the condition. iHarnoorSingh
Source: WSJ - 🏆 98. / 63 Read more »